1. Home
  2. ADXN vs SPHL Comparison

ADXN vs SPHL Comparison

Compare ADXN & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • SPHL
  • Stock Information
  • Founded
  • ADXN 2002
  • SPHL 2002
  • Country
  • ADXN Switzerland
  • SPHL Singapore
  • Employees
  • ADXN N/A
  • SPHL N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • SPHL Homebuilding
  • Sector
  • ADXN Health Care
  • SPHL Consumer Discretionary
  • Exchange
  • ADXN Nasdaq
  • SPHL Nasdaq
  • Market Cap
  • ADXN 8.2M
  • SPHL 7.3M
  • IPO Year
  • ADXN N/A
  • SPHL 2024
  • Fundamental
  • Price
  • ADXN $7.45
  • SPHL $0.42
  • Analyst Decision
  • ADXN Strong Buy
  • SPHL
  • Analyst Count
  • ADXN 1
  • SPHL 0
  • Target Price
  • ADXN $30.00
  • SPHL N/A
  • AVG Volume (30 Days)
  • ADXN 7.7K
  • SPHL 1.3M
  • Earning Date
  • ADXN 04-07-2025
  • SPHL 02-21-2025
  • Dividend Yield
  • ADXN N/A
  • SPHL N/A
  • EPS Growth
  • ADXN N/A
  • SPHL 413.11
  • EPS
  • ADXN 0.06
  • SPHL 0.09
  • Revenue
  • ADXN $701,260.00
  • SPHL $11,020,429.00
  • Revenue This Year
  • ADXN N/A
  • SPHL N/A
  • Revenue Next Year
  • ADXN N/A
  • SPHL N/A
  • P/E Ratio
  • ADXN $0.89
  • SPHL $5.06
  • Revenue Growth
  • ADXN N/A
  • SPHL 112.84
  • 52 Week Low
  • ADXN $6.67
  • SPHL $0.40
  • 52 Week High
  • ADXN $27.90
  • SPHL $7.80
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 47.90
  • SPHL N/A
  • Support Level
  • ADXN $7.16
  • SPHL N/A
  • Resistance Level
  • ADXN $8.05
  • SPHL N/A
  • Average True Range (ATR)
  • ADXN 0.45
  • SPHL 0.00
  • MACD
  • ADXN -0.02
  • SPHL 0.00
  • Stochastic Oscillator
  • ADXN 51.22
  • SPHL 0.00

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd is a company that conducts its operations through its indirect wholly-owned subsidiary which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of works which includes new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation.

Share on Social Networks: